Hypoxic pulmonary hypertension: its modification by dipyridamole.
about
Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.The acute hemodynamic effect of IV nitroglycerin and dipyridamole in patients with pulmonary arterial hypertension: comparison with IV epoprostenol.Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.
P2860
Hypoxic pulmonary hypertension: its modification by dipyridamole.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@en
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@nl
type
label
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@en
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@nl
prefLabel
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@en
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@nl
P2093
P1476
Hypoxic pulmonary hypertension: its modification by dipyridamole.
@en
P2093
J G Rosenkrantz
P304
P356
10.1016/0022-4804(72)90115-1
P577
1972-05-01T00:00:00Z